electroCore Announces Peter Cuneo as Board Chairman
Retrieved on:
Monday, September 20, 2021
Nature, Vagus nerve, Headache, Black, Â, Private Securities Litigation Reform Act, Overalls, Pain, NVN, Hearing, Black+Decker, Union, Cluster headache, Business Insider, Industry, SEC, Safety, Marvel Entertainment, A luta continua, Adult, Tachycardia, IP, Principal, CEO, Bradycardia, Harvard Business School, Migraine, Hypotension, Chief executive officer, Transcutaneous electrical nerve stimulation, Patient, Smartphone, Nerve conduction study, Sale, FDA, Medication overuse headache, Hypertension, Terminology, Company, LLC, Neurology, Non-executive director, Time, Trustee, ElectroCore, GLOBE, Use, Indometacin, Hemicrania continua, Adolescence, ECOR, Board, National Archives Foundation, European Union, COVID-19, MBA, Nasdaq, Skin, Management, Pharmaceutical industry
ROCKAWAY, NJ, Sept. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Board of Directors has appointed Peter Cuneo as Chairman of the Board of Directors effective October 1, 2021.
Key Points:
- ROCKAWAY, NJ, Sept. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Board of Directors has appointed Peter Cuneo as Chairman of the Board of Directors effective October 1, 2021.
- He currently serves as Chairman emeritus of the Alfred University Board of Trustees and on the Board of the National Archives Foundation in Washington, D.C and holds an MBA from Harvard Business School.
- It has been an honor to serve on electroCores Board since April 2020, said Mr. Cuneo.
- As Board Chairman, I look forward to working with our Board members and management team to realize the companys plans for the future.